A multicentre study of nefazodone and sertraline in depressed outpatients

By Burns T.   Kosky N.   Balasubramaniam K.   D'Souza J.   Andrews G.   Freeman C.   Buckingham S.   Hawkings E.   Mellors K.   Ascher A.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 305-306

Elsevier

Access to resources Recommend Favorite

Comparison of the effects of nefazodone and fluoxetine on sleep architecture and sleep efficiency in depressed patients

By Armitage R.   Yonkers K.   Rush A.J.   Cole D.   Novak K.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 299-299

Elsevier

Access to resources Recommend Favorite

Comparison of the safety and tolerance of fluvoxamine and sertraline in depressed outpatients

By Nemeroff C.B.   Ninan P.T.   Ballenger J.C.   Feighner J.   Greist J.H.   Patterson W.M.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 304-304

Elsevier

Access to resources Recommend Favorite

Clinical efficacy of paroxetine in elderly outpatients

By Zarattini F.   Testa L.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 313-314

Elsevier

Access to resources Recommend Favorite

A randomised, double-blind, comparison of the efficacy and safety of venlafaxine (75 to 150 mg/day) versus fluoxetine (20 mg/day) in depressed outpatients

By Salinas E.   Nicholas T.   Hackett D.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 308-308

Elsevier

Access to resources Recommend Favorite